$ 9.4 Billion in Revenue Expected From the Growth of the Lactose Intolerance Treatment Market Worldwide

Development of the lactose intolerance market has been fuelled primarily due to increased focus by industry players. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, recently published a report on this market. The sector is expected to reach $ 9.4 billion by the end of 2023, this market is anticipated to develop at a CAGR of 7.2 % during the forecast period.

Lactose intolerance has become a relatively common health concern globally, with many individuals suffering from the condition. As the condition is induced due to consumption of dairy products, non-dairy products like soy milk, almond milk etc have gained a significant amount of market share. Heightened awareness and improved methods to diagnose the condition have driven the industry positively. Widespread availability of lactose free products will further motivate the growth of the industry in the long term.

Get a sample report at https://www.marketresearchfuture.com/sample_request/3868 .

Industry Segments

The global lactose intolerance treatment market is categorized on the basis of types, treatments and end users. On the basis of type, the market has been segmented into primary, secondary, developmental and congenital. Secondly, based on the treatment, the market has been segmented into food supplements like dairy, milk substitutes (soy, rice, coconut, almond, others), cereals & breads, fats, enzymatic lactase supplements and others. Finally based on end users, the market has been segmented into hospitals and clinics, home use, and others.

Detailed Regional Analysis

Countries like US account for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The regional analysis of the lactose intolerance treatment includes regions such as Asia Pacific, North America, Europe and Rest of the World. The faster market uptake of new technology in the US is also an important driver of the market for global lactose intolerance treatment. Europe is the second largest market mainly due to large disposable income and rising awareness. Asia Pacific region is expected to have the most potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The underprivileged regions of Africa are expected to develop at a slower pace due to poor economic and political conditions in the region and poor healthcare penetration rates.

Global Competitive Analysis

As the sector is transforming in a major way, this has led to an accelerated the growth pace of the sector. Firms are aiming to capture a considerable share of the market segment as early as possible, by experimenting with various advantage points. The industry players in the segment are also utilizing their key resources to initiate a trend of volume-driven growth that has been observed in the market with the development of different varieties of product types. The best long-term growth opportunities for this sector can be tapped by ensuring ongoing process improvements along with maintaining financial flexibility to invest in the optimal strategies.

The prominent players covered in the report are Johnson & Johnson Inc., National Enzyme Company, Vetbiochem India Private Limited, Scimera Partners, Ganeden Biotech, Daiya Foods Inc., Arla Foods among others.

Browse Complete Report at https://www.marketresearchfuture.com/reports/lactose-intolerance-treatment-market-3868 .

Latest Industry News:

Oct 2017 Liggins Institute at Auckland University have conducted a research which shows A2 milk could be a potential solution for lactose intolerance. Conventional milk contains both A1 and A2 types of protein. Some dairy cows naturally produce only the A2 type and this type is more difficult to get hold of and more expensive to process. The scientists at the Liggins Institute have theorized that it could be another option for people who have lactose intolerance and is also another opportunity for the New Zealand dairy industry.

Jan 2018 a small pill-sized sensor which is capable of sensing gases as it travels through the human digestive tract may help doctors diagnose patients' gut conditions like lactose intolerance and irritable bowel syndrome in the future. The scientists tested the electronic sensor on several healthy individuals and established that the device could correctly detect the concentrations of hydrogen, carbon dioxide and oxygen in real time as it passed through the body.

Oct 2017 Ritter Pharmaceuticals Inc, a Century City biotech company that develops therapies for gastrointestinal diseases has raised $23 million to fund a Phase 3 clinical trial for its lactose intolerance treatment. The funding will launch its clinical program for RP-G28, a microbiome modulator designed to stimulate the growth of lactose-metabolizing bacteria in the colon.

About us

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

P: +1 646 845 9312

W: www.marketresearchfuture.com

sales@marketresearchfuture.com

This release was published on openPR.